| Aptamer nanomedicine for cancer therapeutics: barriers and potential for translation YH Lao, KKL Phua, KW Leong ACS nano 9 (3), 2235-2254, 2015 | 278 | 2015 |
| Transfection efficiency and transgene expression kinetics of mRNA delivered in naked and nanoparticle format KKL Phua, KW Leong, SK Nair Journal of Controlled Release 166 (3), 227-233, 2013 | 195 | 2013 |
| Intranasal mRNA nanoparticle vaccination induces prophylactic and therapeutic anti-tumor immunity KKL Phua, HF Staats, KW Leong, SK Nair Scientific reports 4 (1), 5128, 2014 | 136 | 2014 |
| Formulation, characterization and evaluation of mRNA-loaded dissolvable polymeric microneedles (RNApatch) KJ Koh, Y Liu, SH Lim, XJ Loh, L Kang, CY Lim, KKL Phua Scientific reports 8 (1), 11842, 2018 | 91 | 2018 |
| Messenger RNA (mRNA) nanoparticle tumour vaccination KKL Phua, SK Nair, KW Leong Nanoscale 6 (14), 7715, 2014 | 83 | 2014 |
| Synthesis of fluorosurfactants for emulsion-based biological applications YL Chiu, HF Chan, KKL Phua, Y Zhang, S Juul, BR Knudsen, YP Ho, ... ACS nano 8 (4), 3913-3920, 2014 | 71 | 2014 |
| Whole blood cells loaded with messenger RNA as an anti-tumor vaccine KKL Phua, D Boczkowski, J Dannull, S Pruitt, KW Leong, SK Nair Advanced healthcare materials 3 (6), 837, 2013 | 44 | 2013 |
| Towards targeted delivery systems: ligand conjugation strategies for mRNA nanoparticle tumor vaccines KKL Phua Journal of Immunology Research 2015 (1), 680620, 2015 | 32 | 2015 |
| Inducing hair follicle neogenesis with secreted proteins enriched in embryonic skin SMY Fan, CF Tsai, CM Yen, MH Lin, WH Wang, CC Chan, CL Chen, ... Biomaterials 167, 121-131, 2018 | 29 | 2018 |
| Sustained release of PKR inhibitor C16 from mesoporous silica nanoparticles significantly enhances mRNA translation and anti-tumor vaccination W Zhang, Y Liu, JM Chin, KKL Phua European Journal of Pharmaceutics and Biopharmaceutics 163, 179-187, 2021 | 23 | 2021 |
| Messenger RNA translation enhancement by immune evasion proteins: a comparative study between EKB (vaccinia virus) and NS1 (influenza A virus) Y Liu, JM Chin, EL Choo, KKL Phua Scientific reports 9 (1), 11972, 2019 | 23 | 2019 |
| Non-linear enhancement of mRNA delivery efficiencies by influenza A derived NS1 protein engendering host gene inhibition property KKL Phua, Y Liu, SH Sim Biomaterials 133, 29-36, 2017 | 22 | 2017 |
| Microscale oral delivery devices incorporating nanoparticles K Phua, KW Leong Nanomedicine 5 (2), 161-163, 2010 | 15 | 2010 |
| Suppression of mRNA nanoparticle transfection in human fibroblasts by selected interferon inhibiting small molecule compounds Y Liu, MN Krishnan, KKL Phua Biomolecules 7 (3), 56, 2017 | 13 | 2017 |
| Modulation of mRNA translation and cell viability by influenza A virus derived nonstructural protein 1 Y Liu, ZH Chia, JNMH Liew, SM Or, KKL Phua nucleic acid therapeutics 28 (3), 200-208, 2018 | 12 | 2018 |
| Degradable polymers KKL Phua, ERH Roberts, KW Leong Elsevier, 2011 | 12 | 2011 |
| Detection of salivary IgA antibodies against the HlyE antigen as a diagnosis of typhoid fever KL Chin, NEM Redhuan, P Balaram, KK Phua, EBB Ong Journal of clinical and diagnostic research: JCDR 10 (6), DM01, 2016 | 10 | 2016 |
| 1.24 Degradable Polymers KKL Phua, ERH Roberts, KW Leong Elsevier, 2017 | 4 | 2017 |
| Immobilization of nucleic acid binding polymers as anti-inflammatory agent in autoimmunity. Y Zhang, K Phua, HF Chan, B Sullenger, KW Leong Journal of Controlled Release: Official Journal of the Controlled Release …, 2015 | 2 | 2015 |
| Development of Delivery Strategies Facilitating Broad Application of Messenger RNA Tumor Vaccine KKL Phua Duke University, 2014 | | 2014 |
Kam LeongBiomedical Engineering, Columbia UniversityEmail verificata su columbia.edu
